News

The highly anticipated annual biotechnology event — BIO Asia–Taiwan 2025 Exhibition— will be held from July 24 to 27 at the Taipei Nangang Exhibition Center. Amaran Biotech is proud to debut its new brand identity and vision, showcasing major advancements in aseptic filling line, adjuvant technologies, and global partnerships. Visit us at Booth M726, located in the CDMO zone — we warmly welcome industry partners for dialogue and collaboration. As a one-stop Contract Development and Manufacturing Organization (CDMO), Amaran Biotech provides integrated solutions encompassing vaccine adjuvant AB-801 (QS-21), drug substance manufacturing, and aseptic filling of drug products. With the implementation of a […]

Aseptic filling is the final production stage in the pharmaceutical industry and one of the most critical steps. However, the production process for proteins and new therapeutic modalities in aseptic filling faces numerous difficulties and challenges. To further advance the pharmaceutical industry and enhance the understanding of advanced aseptic filling processes among industry professionals and experts, Amaran and Cytiva will co-host the "Advanced Aseptic Processing Technology for Proteins and New Modalities" Workshop, scheduled to be held on Thursday, November 7, 2024, in Zhubei City.

Amaran Biotech, a leading Taiwanese CDMO (Contract Development & Manufacturing Organization) offering comprehensive pharmaceutical development and manufacturing solutions, is making its debut at BioJapan 2024 in Yokohama from October 9 to 11. The company is participating as part of Taiwan’s Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) delegation. Amaran Biotech will showcase its services at the Taiwan Pavilion (Booth No. B-56), including its vaccine adjuvant AB-801 (QS-21), drug substance manufacturing, drug product manufacturing, and stability study and analytical science services. Visitors are invited to meet with Amaran Biotech's representatives at the event.

BIO Asia–Taiwan 2024, an international gathering jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO); will be held from July 24th to 28th at the Taipei Nangang Exhibition Center. Amaran Biotech’s booth(#M413) will be located at CDMO (Contract Development and Manufacturing Organization) zone, please visit us and meet with our representatives.

BIO Asia–Taiwan 2023, an international gathering jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO); will be held from July 27th to 30th at the Taipei Nangang Exhibition Center, Hall 1 (TaiNEX 1).

The world's largest biotechnology industry event "BIO International Convention 2023" will be held at the Boston Convention & Exhibition Center on June 5-8. Amaran Biotech, is invited by the Biotechnology and Pharmaceutical Industries Promotion Office, Ministry of Economic Affairs (BPIPO, MOEA) and the Taiwan External Trade Development Council (TAITRA), will jointly exhibit at the "Taiwan Pavilion".

Amaran Biotechnology Inc., a subsidiary of Taiwan’s OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first in Taiwan, has been completed. The new facility minimizes the risks of human factors affecting the quality of the pharmaceutical products, and substantially enhances their safety. The project is now entering the final process validation phase of the medium fill procedures.

BioAsia-Taiwan 2019 will take place in the Taipei Nangang Exhibition Center and CTBC Financial Park on July 24 to July 28. BioTaiwan has established itself as one of the largest annual biotech events in Asia for the past 16 years. The Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan Bio) have come together to present BioAsia-Taiwan. This year’s event themed “Biotech as the Next Growth Engine for Asia" will attract more than 1,500 attendees from 25 countries.